HomeCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
Previous close
$150.21
Day range
$150.18 - $153.72
Year range
$91.86 - $254.15
Market cap
7.45B USD
Avg Volume
917.57K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 984.17M | -2.71% |
Operating expense | 206.08M | -1.77% |
Net income | 25.47M | -62.17% |
Net profit margin | 2.59 | -61.11% |
Earnings per share | 2.34 | 3.08% |
EBITDA | 218.88M | -4.14% |
Effective tax rate | 28.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 229.36M | -29.87% |
Total assets | 7.58B | -7.00% |
Total liabilities | 4.34B | -2.43% |
Total equity | 3.24B | — |
Shares outstanding | 49.12M | — |
Price to book | 2.31 | — |
Return on assets | 4.43% | — |
Return on capital | 5.35% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 25.47M | -62.17% |
Cash from operations | 171.70M | 32.19% |
Cash from investing | -45.48M | 46.99% |
Cash from financing | -105.32M | -674.10% |
Net change in cash | 26.16M | -51.61% |
Free cash flow | 147.04M | 279.41% |
About
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in preclinical and clinical laboratory, gene therapy and cell therapy services and supplies for the pharmaceutical, medical device and biotechnology industries.
The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories frequently criticized by animal rights activists, who condemn the company's use of dogs and primates for pharmaceutical research. The company is also a major harvester of blood from horseshoe crabs. Wikipedia
Founded
1947
Headquarters
Website
Employees
19,400
